I70.663 Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, bilateral legs

Name of the Condition

• Common Name: Atherosclerosis of Bypass Grafts with Gangrene (Bilateral Legs)
• Medical Term: Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, bilateral legs
• ICD-10 Code: I70.663

Summary

Atherosclerosis of nonbiological bypass graft(s) of the extremities with gangrene, bilateral legs refers to plaque buildup in synthetic or non-living bypass grafts used to restore blood flow to both legs, accompanied by tissue death (gangrene). This condition occurs when fatty deposits, cholesterol, and other substances accumulate within the grafts, narrowing or blocking blood flow and leading to severe ischemia in both lower limbs. The gangrene indicates irreversible tissue damage due to prolonged lack of oxygen and nutrients.

Causes

Atherosclerosis in nonbiological bypass grafts develops due to damage to the graft's inner lining, often triggered by factors like turbulent blood flow, mechanical stress, or systemic atherosclerosis. Over time, plaque accumulates at the site of injury, thickening and hardening the graft walls, which restricts blood flow and increases the risk of graft failure. The condition is exacerbated by the same processes that drive natural atherosclerosis, occurring within the synthetic graft material. Severe narrowing or occlusion of the grafts can lead to critical ischemia and subsequent gangrene in both legs.

Risk Factors

• Age (more common in older adults)
• History of atherosclerosis or cardiovascular disease
• High cholesterol or triglyceride levels
• Hypertension (high blood pressure)
• Smoking or tobacco use
• Diabetes or insulin resistance
• Obesity or sedentary lifestyle
• Poor diet (high in saturated fats, trans fats, or sodium)
• Previous bypass surgery or graft placement

Symptoms

• Severe leg pain or cramping, especially during activity (claudication)
• Non-healing ulcers or sores on the legs or feet
• Discoloration of the skin (pale, bluish, or dark)
• Coldness or numbness in the legs or feet
• Gangrene (tissue death) in the toes, feet, or lower legs
• Weak or absent pulses in the affected limbs

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging, and laboratory tests. A healthcare provider will assess symptoms, review medical history, and perform a physical exam to check for pulses, skin changes, or ulcers. Imaging studies such as Doppler ultrasound, angiography, or CT angiography may be used to visualize blood flow and identify blockages in the grafts or arteries. Blood tests may assess cholesterol levels, blood sugar, or markers of inflammation. Tissue samples (biopsy) may be taken if gangrene is present to confirm tissue death and rule out infection.

Treatment Options

Treatment focuses on restoring blood flow, managing symptoms, and preventing complications. Revascularization procedures, such as angioplasty, stenting, or surgical revision of the graft, may be performed to reopen blocked grafts. Medications like antiplatelet agents (e.g., aspirin), cholesterol-lowering drugs (statins), or blood pressure medications may be prescribed. In severe cases, amputation of the affected tissue may be necessary. Wound care and infection prevention are critical for gangrenous areas. Lifestyle modifications, including smoking cessation and diet changes, are also recommended.

Prognosis and Follow-Up

Prognosis depends on the extent of graft damage, overall health, and response to treatment. Early intervention can improve outcomes, but advanced gangrene may lead to limb loss or systemic complications. Regular follow-up with a healthcare provider is essential to monitor graft function, manage risk factors, and adjust treatment. Long-term care may include ongoing imaging, medication management, and lifestyle support to prevent recurrence or progression.

Complications

• Limb loss (amputation) due to severe gangrene
• Infection of gangrenous tissue
• Systemic sepsis from untreated infection
• Graft failure or occlusion
• Chronic pain or disability
• Reduced quality of life

Lifestyle & Prevention

• Quit smoking or avoid tobacco use
• Maintain a heart-healthy diet low in saturated fats and sodium
• Engage in regular physical activity as recommended by a healthcare provider
• Manage blood pressure, cholesterol, and blood sugar levels
• Follow post-surgical care instructions for graft maintenance
• Inspect feet daily for sores or changes in color/sensation

When to Seek Professional Help

Seek immediate medical attention if you experience:

• Sudden severe leg pain or swelling
• Darkening or discoloration of the skin on the legs or feet
• Non-healing sores or ulcers
• Fever or signs of infection (redness, warmth, pus)
• Numbness or coldness in the legs that does not improve

Tips for Medical Coders

When coding I70.663, ensure documentation specifies:

• The presence of atherosclerosis in nonbiological bypass grafts (synthetic or non-living material)
• Bilateral involvement of the legs
• Gangrene as a complication
• Clinical correlation with symptoms, imaging, or surgical findings
• Exclusion of other causes of gangrene (e.g., infection, trauma) if applicable
• Accurate reporting of laterality (bilateral) and the specific graft type (nonbiological) to align with code requirements.